Modifying QALY

Author(s)

Ogorevc M1, Prevolnik Rupel V2
1Institute for Economic Research, BRINJE, LJUBLJANA, 061, Slovenia, 2DOBA Faculty, Maribor, Slovenia

Presentation Documents

OBJECTIVES: Recently, some health technology assessment (HTA) agencies started using disease severity modifier to place more weight on severe health states with respect to QALY, although there is little evidence indicating that such modifier aligns with societal preferences. The aim of this paper is to bridge the gap in providing empirical justification for the use of disease severity modifiers in HTA.

METHODS: A discrete choice experiment (DCE) has been in an on-line (BrevisVelox.com) survey with a representative sample of 500 respondents from Slovenia. Each task (out of five) presented two hypothetical patients that differed in the age at onset of the disease, age at death with and without health intervention, reduction of Health Related QoL (HRQoL) without health intervention or increase of HRQoL due to health intervention. The subjects were asked to choose which of the two hypothetical patients was more eligible for health intervention. Analysis was performed using a mixed logit model in R.

RESULTS: After controlling for the QALYs gained, statistically significant coefficients were observed in all variables. Patient’s age at the onset of the disease was negatively associated with health intervention preferences. Reduction in HRQoL without health intervention had a statistically significant, negative, and larger (in absolute terms) coefficient compared to the increase in HRQoL due to health intervention. Furthermore, extending life due to health intervention had a positive and statistically significant effect.

CONCLUSIONS: A fixed cost-effectiveness threshold is not in line with Slovenian general population preferences. The respondents were more willing for (equally effective) health intervention to be provided for younger, more severely ill patients, and for health interventions that prolong life more than the conventional HTA would assume. A modifier that takes into account societal preferences should be used by the national HTA agency.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

PCR85

Topic

Economic Evaluation, Health Policy & Regulatory, Patient-Centered Research

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis, Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes, Reimbursement & Access Policy

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×